No Data
Pharmaceutical stocks have become a transitional theme at present, and the performance line may be further valued by the market.
Track the entire lifecycle of the main sector.
The seasonal influenza A has entered the epidemic period, and the sales of related Chinese Patent Medicine products have significantly increased.
① Recently, the positive rate of influenza virus has significantly increased, with over 99% being type A influenza. Market data shows a clear increase in the demand for various Traditional Chinese Medicine cold medicine products. ② Today, stock prices of several listed companies in the Traditional Chinese Medicine Industry, such as Shanxi Zhendong Pharmaceutical, Hainan Huluwa Pharmaceutical Group, and Zhongsheng Pharmaceutical, have reached the daily limit, with the Traditional Chinese Medicine Sector overall rising, and the Traditional Chinese Medicine 50 ETF increasing by 3.21%.
How is the quality and supply of Pharmaceuticals guaranteed? The National Healthcare Security Administration held a symposium on centralized procurement of Pharmaceuticals.
On December 26, 2024, the National Healthcare Security Administration held a symposium on centralized procurement of Pharmaceuticals, inviting representatives from the National Medical Products Administration, selected Pharmaceutical enterprises, and research Institutions to communicate and exchange views on recent societal concerns regarding quality assurance of centrally procured Pharmaceuticals and innovative development in the Industry, and to listen to opinions and suggestions.
Zhongzhi Pharmaceutical Invests in US Biotech Firm to Advance Alzheimer's Treatment
Hong Kong stock market news for December 24: The three major US Indexes closed higher. HKEX has a half-day trading session due to Christmas.
① Consumer confidence in the USA has declined for the first time in three months. ② The three major US stock indices collectively closed higher on Monday, with most China Concept Stocks showing strength. ③ Musk criticized the Federal Reserve, claiming there are absurdly many employees under Powell. ④ The NASDAQ 100 Index is rebalanced, with the weight of Tesla, Meta, and Broadcom decreasing. ⑤ HKEX will have a half-day Trade session on Christmas Eve.
ZHONGZHIPHARM (03737.HK) has signed an investment agreement with the USA Biomedical company GABAeron Inc.
On December 23, Gelonghui reported that ZHONGZHIPHARM (03737.HK) announced that on December 21, 2024, the group held an investment agreement signing ceremony with the USA Biomedical company GABAeron Inc. in Zhongshan. Dr. Huang Yadong, the co-founder and chairman of GABAeron and a renowned neuroscientist, ZHONGZHIPHARM Chairman Lai Zhitian, General Manager Wan Hequn and Deputy General Manager Yu Conghong of Zhongshan Health Base Group Co., Ltd. were present at the event to witness the signing ceremony, along with Vice Presidents Cao Xiao-Jun and Qiao Weilin, Chief Financial Officer Lai Yingsheng, and Lawyer Wang Lifeng.
No Data
